The VVHA Antibody (PAC061806) is a polyclonal antibody specifically designed for research involving VVHA, a protein associated with the immune system and immune regulation. This antibody, produced using advanced technology, is highly reactive with VVHA in human samples and has been validated for use in various applications, including Western blotting.VVHA is an important immune regulator that plays a crucial role in modulating immune responses and maintaining immune homeostasis. Research on VVHA is particularly relevant in the fields of immunology and cancer research, as the protein is implicated in pathways that regulate inflammation, allergic reactions, and immune system function.
By using the VVHA Antibody, researchers can effectively detect and analyze VVHA protein levels in different cell types, providing valuable insights into its functions and potential implications in various disease states. This antibody is a valuable tool for studies aiming to understand the role of VVHA in immune regulation and its potential as a therapeutic target in conditions such as cancer, autoimmune disorders, and chronic inflammatory diseases.
Antibody Name:
vvhA Antibody (PACO61806)
Antibody SKU:
PACO61806
Size:
50ul
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:5000
Species Reactivity:
Vibrio vulnificus
Immunogen:
Recombinant Vibrio vulnificus Cytolysin protein (21-471AA)
Western Blot. Positive WB detected in Recombinant protein. All lanes: vvhA antibody at 2.3µg/ml. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 58 kDa. Observed band size: 58 kDa.
Background:
Bacterial hemolysins are exotoxins that attack blood cell membranes and cause cell rupture by mechanisms not clearly defined.
Synonyms:
Cytolysin, vvhA
UniProt Protein Function:
Bacterial hemolysins are exotoxins that attack blood cell membranes and cause cell rupture by mechanisms not clearly defined.
